About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNANCT03564275

Proton Boost in Prostate Cancer

This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation the...

Lead sponsor: University of Cincinnati•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Cincinnati

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•≥18 years of age
•Diagnosis of low risk prostate cancer (T1c-T2a, Gleason 6, Prostate Specific Antigen (PSA) \<10) -OR-
•Diagnosis of intermediate risk prostate cancer (T1c-T2c, Gleason 7 and/or PSA 10- 20)
•Life expectancy \>10 yrs
•Physically and mentally capable of signing the consent form of their own volition

Exclusion Criteria

•\< 18 years of age
•Diagnosis of high risk prostate cancer (T3 or higher, Gleason \>7 and/or PSA \>20)
•Current or historical use of androgen deprivation therapy
•Nodal positivity
•Previous cancer excluding non-melanoma skin cancer
•History of prostatectomy
•History of brachytherapy for prostate cancer
•Life expectancy \<10 yrs
•Physically or mentally incapable of signing the consent form of their own volition

Related studies

A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

NCT06363266 · Cancer of the Prostate, Anxiety

Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System

NCT07109427 · Prostate Cancer, Cancer of the Prostate

MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

NCT05241236 · Neoplasms Prostate, Cancer of the Prostate

Not Yet RecruitingNA

Low-Count Quantitative SPECT for Men Treated With Radium-223

NCT07221825 · Prostate Cancer, Cancer of the Prostate

COMPLETEDPhase 2

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

NCT03939689 · Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 31, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment10

Start dateApr 2018

Last updatedMay 31, 2025

Condition

Cancer of the Prostate

Locations shown

University of Cincinnati

Cincinnati, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 31, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions